nearly 2 billion dollars

By 

Jared S. Hopkins

 and Chris Wack

Updated July 22, 2020 5:36 pm ET

•  
  PRINT
•  
  TEXT

The U.S. has agreed to pay Pfizer Inc. and BioNTech SE nearly $2 billion to secure 100 million doses of their experimental Covid-19 vaccine to provide to Americans free of charge, the latest sign the government is readying plans to make vaccines available if proved to work safely.